Surgical 5-year Outcomes of Extra-Anatomical Bypass for Middle Aortic Syndrome: A Case Series

Abstract

Background

Middle aortic syndrome is a rare disease. Several surgical treatments are available; however, the optimal treatment strategy and long-term outcomes remain unelucidated. We herein report the 5-year outcomes of six patients treated with extra-anatomical bypass surgery for middle aortic syndrome.

Case presentations

Between 2013 and 2016, six patients underwent extra-anatomical bypass for middle aortic syndrome at our institute: three had Takayasu’s arteritis, one had vessel vasculitis, and two had middle aortic hypoplastic syndrome of unknown origin. The patients included five women and one man, with a mean age of 59.7 years. Four patients had uncontrolled hypertension and were receiving antihypertensive medications. The mean ankle–brachial pressure index was .61. The three patients with Takayasu’s arteritis were hospitalized for congestive heart failure. These patients underwent bypass surgery from the descending aorta to the infrarenal abdominal aorta, and one also underwent concomitant heart surgery. The patient with microscopic polyangiitis underwent Y-grafting with an aortic aneurysmectomy. Subsequently, bypass surgery was performed from the descending aorta to the graft via the diaphragm. The two patients with unknown causes underwent bypass surgery from the proximal descending aorta to the distal descending thoracic aorta. There were no early or late deaths at the 5-year follow-up. We did not observe any changes in anastomotic site stenosis or new aneurysmal changes during the follow-up period. The number of antihypertensive medications was reduced in all cases, and critical symptoms, including headache, severe abdominal pain, claudication, and heart failure, improved in all patients. The ankle–brachial pressure index increased to 1.11 and did not change for five years. Renal function remained stable, and the brain natriuretic peptide level decreased from 302.8 to 74.5 pg/mL at follow-up.

Conclusion

Extra-anatomical bypass for middle aortic syndrome is safe and effective, and can help prevent renal failure, and relieve critical ischemic symptoms.

Keywords

extra-anatomical bypass middle aortic syndrome small-vessel vasculitis Takayasu’s arteritis

Get full access to this article

View all access options for this article.

References

Messina

Reilly

Goldstone

Ehrenfeld

Ferrell

Stoney

. Middle aortic syndrome. Effectiveness and durability of complex arterial revascularization. Ann Surg. 1986;204:331. https://dx.doi.org/10.1097%2F00000658-198609000-00012.

Murayama

Inagaki

Watanabe

, et al. Acute heart failure due to midaortic occlusion as the initial manifestation of Takayasu arteritis. Circ Heart Fail. 2009;2:74-76. https://doi.org/10.1161/circheartfailure.108.783837.

Connolly

Wilson

Lawrence

Fujitani

. Middle aortic syndrome: distal thoracic and abdominal coarctation, a disorder with multiple etiologies. J Am Coll Surg. 2002;194:774-781. https://doi.org/10.1016/s1072-7515(02)01144-4.

Delis

Gloviczki

. Middle aortic syndrome: from presentation to contemporary open surgical and endovascular treatment. Perspect Vasc Surg Endovasc Ther. 2005;17:187-203. https://doi.org/10.1177/153100350501700302.

Kim

Jung

Han

, et al. Surgical treatment of middle aortic syndrome with Takayasu arteritis or midaortic dysplastic syndrome. Eur J Vasc Endovasc Surg. 2015;50:206-212. https://doi.org/10.1016/j.ejvs.2015.04.032.

Jung

Song

Choi

Jeong

Kim

Choi

. Endovascular intervention versus surgery in patients with Takayasu’s arteritis: a meta-analysis. Eur J Vasc Endovasc Surg. 2018;55:888-899. https://doi.org/10.1016/j.ejvs.2018.02.030.

Saadoun

Lambert

Miraultetal

, et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation. 2012;125:813-819. https://doi.org/10.1161/circulationaha.111.058032.

Keser

Direskeneli

Aksu

. Management of Takayasu arteritis: a systematic review. Rheumatology. 2014;53:793-801. https://doi.org/10.1093/rheumatology/ket320.

Seyahi

. Takayasu arteritis: an update. Curr Opin Rheumatol. 2017;29:51-56. https://doi.org/10.1097/bor.0000000000000343.

10.

Martin

Diamond

Casarella

. Percutaneous transluminal angioplasty in non-atheroscklerotic disease. Radiology. 1980;135:27-33. https://doi.org/10.1148/radiology.135.1.6127750.

11.

Che

Xiong

Jiang

, et al. Stenting for middle aortic syndrome caused by Takayasu arteritis-immediate and long-term outcomes. Catheter Cardiovasc Interv. 2018;91:623-631. https://doi.org/10.1002/ccd.27492.

12.

Kim

Jung

Han

, et al. Surgical treatment of middle aortic syndrome with Takayasu arteritis or midaortic dysplastic syndrome. Eur J Vasc Endovasc Surg. 2015;50:206-212. https://doi.org/10.1016/j.ejvs.2015.04.032.

13.

Kim

Cho

Sung

, et al. Clinical outcome of extraanatomic bypass for midaortic syndrome caused by Takayasu arteritis. Ann Thorac Surg. 2020;109:1419-1425. https://doi.org/10.1016/j.athoracsur.2019.08.032.

14.

Mao

Zhao

, et al. Treatment of middle aortic syndrome with thoraco-abdominal aortic bypass grafting assisted by endoscope in adult. Perfusion. 2021;7:267659120986773. https://doi.org/10.1177/0267659120986773.

15.

Lopez-Pena

Anaya-Ayala

Garcia-Alva

Arzola

Luna

Hinojosa

. Complex aortic, visceral and renal arteries reconstruction with a four-branch Dacron graft for middle aortic syndrome secondary to Takayasu's arteritis. Ann Vasc Surg. 2020. https://doi.org/10.1016/j.avsg.2020.05.064.

16.

Luu

Pulcrano

Hua

. Surgical management of middle aortic syndrome in an adult. J Vasc Surg Cases Innov Tech. 2020;12:38-40.

17.

Cronenwett

Johnson

, eds Rutherford's Vascular Surgery. 7th ed.. New York: Elsevier Health Sciences; 2009.

18.

Taketani

Miyata

Morota

Takamoto

. Surgical treatment of atypical aortic coarctation complicating Takayasu's arteritis – experience with 33 cases over 44 years. J Vasc Surg. 2005;41:597-601. https://doi.org/10.1016/j.jvs.2005.01.022.

19.

Cramariuc

Gerdts

. Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic. Expert Rev Cardiovasc Ther. 2016;14:915-926. https://doi.org/10.1080/14779072.2016.1186542.